(Q37752365)

22 August 2017

1 reference

title

Seizures in low- and high-grade gliomas: current management and future outlook (English)

1 reference

22 August 2017

Charles J Vecht

1

1 reference

22 August 2017

Erik B Wilms

series ordinal

2

1 reference

22 August 2017

publication date

1 May 2010

1 reference

Expert Review of Anticancer Therapy

22 August 2017

published in

1 reference

22 August 2017

volume

10

1 reference

22 August 2017

issue

5

1 reference

22 August 2017

page(s)

663-669

1 reference

Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery

22 August 2017

cites work

1 reference

Epilepsy after brain insult: targeting epileptogenesis

21 January 2018

1 reference

Expression of gap junction genes in astrocytes and C6 glioma cells

21 January 2018

1 reference

Changes in gamma-aminobutyric acid and somatostatin in epileptic cortex associated with low-grade gliomas

21 January 2018

1 reference

Ionotropic and metabotropic glutamate receptor protein expression in glioneuronal tumours from patients with intractable epilepsy

21 January 2018

1 reference

Magnetoencephalography (MEG) predicts focal epileptogenicity in cavernomas

21 January 2018

1 reference

Influences of brain tumor-associated pH changes and hypoxia on epileptogenesis

21 January 2018

1 reference

The pathogenesis of tumour associated epilepsy

21 January 2018

1 reference

Seizure prophylaxis in patients with brain tumors: a meta-analysis.

21 January 2018

1 reference

Medical management of patients with brain tumors

21 January 2018

1 reference

Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs

21 January 2018

1 reference

Interactions between antiepileptic and chemotherapeutic drugs

21 January 2018

1 reference

Drug interactions between chemotherapeutic regimens and antiepileptics.

21 January 2018

1 reference

Nitroso-urea-cisplatin-based chemotherapy associated with valproate: increase of haematologic toxicity

21 January 2018

1 reference

Decreased phenytoin levels in patients receiving chemotherapy

21 January 2018

1 reference

Value of therapeutic drug monitoring in epilepsy

21 January 2018

1 reference

Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence

21 January 2018

1 reference

21 January 2018

1 reference

Hematologic toxicity of sodium valproate

21 January 2018

1 reference

Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma.

21 January 2018

1 reference

Blood-brain barrier active efflux transporters: ATP-binding cassette gene family

21 January 2018

1 reference

Role of multidrug transporters in pharmacoresistance to antiepileptic drugs

21 January 2018

1 reference

Pharmacoresistance and expression of multidrug transporter P-glycoprotein in kindled rats

21 January 2018

1 reference

Valproic acid is not a substrate for P-glycoprotein or multidrug resistance proteins 1 and 2 in a number of in vitro and in vivo transport assays

21 January 2018

1 reference

Optimizing therapy of seizures in patients with brain tumors

21 January 2018

1 reference

P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy

21 January 2018

1 reference

Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma

21 January 2018

1 reference

Pharmacokinetic considerations in the treatment of CNS tumours

21 January 2018

1 reference

Antiepileptic treatment in paediatric oncology--an interdisciplinary challenge

21 January 2018

1 reference

Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management

21 January 2018

1 reference

Should enzyme-inducing antiepileptic drugs be considered first-line agents?

21 January 2018

1 reference

Drug interactions involving the new second- and third-generation antiepileptic drugs

21 January 2018

1 reference

Treatment of epilepsy in adults: expert opinion, 2005.

21 January 2018

1 reference

Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC-cortical tubers

21 January 2018

1 reference

SV2A protein is a broad-spectrum anticonvulsant target: functional correlation between protein binding and seizure protection in models of both partial and generalized epilepsy

21 January 2018

1 reference

Effect of levetiracetam on the pharmacokinetics of adjunctive antiepileptic drugs: a pooled analysis of data from randomized clinical trials

21 January 2018

1 reference

Levetiracetam: preliminary experience in patients with primary brain tumours

21 January 2018

1 reference

Efficacy of anti-epileptic drugs in patients with gliomas and seizures.

21 January 2018

1 reference

Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients

21 January 2018

1 reference

Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery

21 January 2018

1 reference

Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study

21 January 2018

1 reference

Effects of levetiracetam as an add-on therapy on cognitive function and quality of life in patients with refractory partial seizures

21 January 2018

1 reference

Central nervous system adverse effects of new antiepileptic drugs. A meta-analysis of placebo-controlled studies.

21 January 2018

1 reference

Safety and pharmacokinetics of intravenous levetiracetam infusion as add-on in status epilepticus

21 January 2018

1 reference

Pharmacotherapy of epileptic seizures in glioma patients: who, when, why and how long?

21 January 2018

1 reference

Valproate-associated coagulopathies are frequent and variable in children

21 January 2018

1 reference

Preoperative valproate administration does not increase blood loss during temporal lobectomy

21 January 2018

1 reference

Absence of bleeding complications in patients undergoing cortical surgery while receiving valproate treatment

21 January 2018

1 reference

The activity of antiepileptic drugs as histone deacetylase inhibitors

21 January 2018

1 reference

Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC.

21 January 2018

1 reference

Valproic acid inhibits proliferation and induces apoptosis in acute myeloid leukemia cells expressing P-gp and MRP1.

21 January 2018

1 reference

Meta-analysis and indirect comparisons of levetiracetam with other second-generation antiepileptic drugs in partial epilepsy.

21 January 2018

1 reference

Outcome and tolerability of topiramate in brain tumor associated epilepsy.

21 January 2018

1 reference

Benefit of combination therapy in epilepsy: a review of the preclinical evidence with levetiracetam

21 January 2018

1 reference

Neurocognitive sequelae in the treatment of low-grade gliomas

21 January 2018

1 reference

Epilepsy in low‐grade gliomas: The impact on cognitive function and quality of life

21 January 2018

1 reference

The course of neurocognitive functioning in high-grade glioma patients.

21 January 2018

1 reference

The spectrum of long-term epilepsy-associated tumors: long-term seizure and tumor outcome and neurosurgical aspects

21 January 2018

1 reference

Surgical treatment for epilepsy

21 January 2018

1 reference

Effect of cranial irradiation on seizure frequency in adults with low-grade astrocytoma and medically intractable epilepsy

21 January 2018

1 reference

First-line nitrosourea-based chemotherapy in symptomatic non-resectable supratentorial pure low-grade astrocytomas

21 January 2018

1 reference

Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response

21 January 2018

1 reference

Effect of ionizing radiation on partial seizures attributable to malignant cerebral tumors

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERA.10.48

1 reference

22 August 2017

1 reference